Answers are grounded in this paper and cite their sources.
Cost–benefit decision-making requires animals to integrate prospective rewards with the costs of obtaining them and translate these evaluations into motivated action. How population activity is coordinated across the frontal–basal ganglia network during these processes remains incompletely understood. Here, we recorded simultaneously from the anterior cingulate cortex, medial/ventral orbitofrontal cortex, dorsomedial striatum, ventral pallidum and subthalamic area in rats performing a cost–benefit decision task. Using canonical correlation analysis, we identified shared population activity across these anatomically distributed circuits and characterised its dimensionality, task–related information and relationship to behavioural sensitivity. The strength and dimensionality of inter-area coupling varied across task epochs and circuit classes, with frontal–basal ganglia interactions exhibiting particularly high dimensionality during reward pursuit. Shared activity represented reward and time on task (trial count) during decision–making, while movement–related information became increasingly prominent during reward pursuit. These representations also depended on subsequent choice: reward was more strongly represented on accepted trials, whereas time on task was more prominent on rejected trials. The strength of inter–area coupling was further associated with behavioural sensitivity across sessions. Stronger coupling between the subthalamic area and the dorsomedial striatum was associated with reduced reward sensitivity. By contrast, communication between the medial/ventral orbitofrontal cortex and dorsomedial striatal was associated with reduced effort aversion. Together, these findings reveal a dynamic, circuit-specific organisation of shared neural activity during cost–benefit behaviour and link inter–area coupling to variation in motivated choice. They suggest that distinct communication pathways may contribute to specific facets of motivated choice, with applications to targeted neuromodulation therapies for disorders of motivation.
No takes yet. Share an insight, caveat, or question.
Härmson et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: